The Central Government Health Scheme, a health ministry arm which serves over 4 million beneficiaries in 25 cities, has managed…
Ansal API, the Rs 700-crore real estate firm, is planning to set up an 80-acre biotech park in Lucknow at…
The US Food and Drug Administration has rapped Ranbaxy?s US-based subsidiary, Ohm Labs Inc, for manufacturing an old ?unapproved drug??opium…
In what could boost business prospects of Indian generic drug makers in the $4-billion plus pharma market of Sweden, the…
The cost of latest versions of medical devices like ultrasound systems, cardiac diagnostics could fall by 25 to 30% compared…
The largest pharma research company Pfizer Inc?s regional president for south-east Asia, Gerry Bacarro, was in Karnal late last week…
In a bid to strengthen its focus on clinical trials research, the country’s second largest hospital chain, Fortis Healthcare Ltd…
The country?s second largest hospital chain, Fortis Healthcare Ltd is scanning the South East Asian market for hospital acquisitions.
In the legal mesh of pharma patent litigations in the largest drug market?the US?Lupin Pharma, Sun Pharma, Ranbaxy Labs Ltd…
Delhi-based Panacea Biotec has bagged the opportunity to fulfill the country?s requirement for bivalent oral polio vaccine.
The UK government agency, One NorthEast, is aggressively scouting for partnership opportunities in the domestic pharma industry in the area…
All the three Indian biotech players ? Serum Institute of India Ltd, Bharat Biotech and Panacea Biotec Ltd ? are…
In one stroke, Swiss pharma giant Novartis AG could break into the league of top five players in the Rs…
Strict label standards are in the offing for pharmaceutical products and medical devices. Following this drug makers engaged in contract…
Despite five established domestic drug firms manufacturing and marketing the H1N1 drug, Oseltamivir, at half the cost in…
Apart from goading the Centre to move the WTO against the recent drug seizures in Europe…
To reduce over dependence on the private sector for the H1N1 drug, Oseltamivir, the government could soon start scouting for…
The drug used for firstline treatment of swineflu, Oseltamivir, may be brought under price regulation in the country.
